Tetrahydro-4-quinolinamines identified as novel P2Y1 receptor antagonists
摘要:
High-throughput screening of the GSK compound collection against the P2Y1 receptor identified a novel series of tetrahydro-4-quinolinamine antagonists. Optimal substitution around the piperidine group was pivotal for ensuring activity. An exemplar analog from this series was shown to inhibit platelet aggregation. (C) 2008 Elsevier Ltd. All rights reserved.